Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
NCT ID:
NCT02322320
Group ID:
EG002
Title:
Lenalidomide Maintenance
Description:
Initial autologous transplant followed by lenalidomide maintenance
Lenalidomide: In BMT CTN 0702, maintenance therapy with lenalidomide started at 10 mg daily for three months and increased to 15 mg daily. The duration of maintenance was three years in all treatment arms. Lenalidomide will be administered initially at the patient's last documented dose prior to discontinuation of BMT CTN 0702 lenalidomide maintenance therapy. Cycle duration is 28 days. Patients will continue lenalidomide until disease progression, or discontinuation due to toxicity, death, or withdrawal from the study.
Deaths Number Affected:
2
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
89
Other Number Affected:
0
Other Number At Risk:
89
Study:
NCT02322320
Results Section:
NCT02322320
Adverse Events Module:
NCT02322320